Counselors in Bloomingdale, NJ Accepting Medicare
4 Counselors found. Showing 1 - 4
 Scott Andrew Mcgill, M.ED., CRC., LRC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 45 Knolls Rd, Bloomingdale, NJ 07403 Phone: 973-641-2691 |
 Mrs. Dawn Fuller Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1 James Ave, Bloomingdale, NJ 07403 Phone: 973-519-2686 |
Martha Gavilanes-osorio, LMHC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 32 Lakeside Ave, Bloomingdale, NJ 07403 Phone: 201-926-4371 |
Ms. Stacy Morales Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 5313 Avalon Way, Bloomingdale, NJ 07403 Phone: 201-741-3605 |
News Archive
Berkeley Lab scientists create atomic-scale structure of ribosome
This may look like a tangle of squiggly lines, but you're actually looking at a molecular machine called a ribosome. Its job is to translate DNA sequences into proteins, the workhorse compounds that sustain you and all living things.
Updated clinical guidelines presented at EAU Anniversary Congress
A number of updated guidelines are presented at the Anniversary Congress of the European Association of Urology (EAU) held in Barcelona, from 16 through 20 April. The abridged versions - Pocket Guidelines - which are based on the extended text documents will also be available in Barcelona to all EAU members and press.
Predictive language models' underlying function more closely resembles the human brain
In the past few years, artificial intelligence models of language have become very good at certain tasks. Most notably, they excel at predicting the next word in a string of text; this technology helps search engines and texting apps predict the next word you are going to type.
New GAO report shows price increase for brand-name drugs doubles from 2000 to 2008
A new report from the Government Accountability Office (GAO) that finds "extraordinary price increases" for brand-name drug products from 2000 – 2008 was largely fueled by the "lack of therapeutically equivalent drugs" and "limited competition," underscores the need for policymakers to promote policies in health reform which increase competition and lower costs, the Pharmaceutical Care Management Association (PCMA) said today.
› Verified 1 days ago